Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NiQoLe: Niraparib Tolerability in Ovarian Cancer
NCT03752216Phase 4Completed
- Sponsor
- ARCAGY
- Start
- Apr 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of niraparib in ovarian cancer, sponsored by ARCAGY. Started Apr 2019; status: completed.
02
Drugs
niraparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03752216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752216.